Sutro Biopharma (STRO) Net Margin Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,849.00 |
| 10 | Sutro Biopharma | 248.39 Mn | 248.39 Mn | - | -173,899.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -173,899.00 |
| Sep 30, 2025 | -1,396.00 |
| Jun 30, 2025 | 25,172.00 |
| Mar 31, 2025 | -69,854.00 |
| Dec 31, 2024 | 100,326.00 |
| Sep 30, 2024 | -28,141.00 |
| Jun 30, 2024 | 10,023.00 |
| Mar 31, 2024 | -5,261.00 |
| Dec 31, 2023 | 42,808.00 |
| Sep 30, 2023 | -21,371.00 |
| Jun 30, 2023 | -27,741.00 |
| Mar 31, 2023 | 26,832.00 |
| Dec 31, 2022 | -4,292.00 |
| Sep 30, 2022 | 28,533.00 |
| Jun 30, 2022 | -7,065.00 |
| Mar 31, 2022 | -52,904.00 |
| Dec 31, 2021 | -2,098.00 |
| Sep 30, 2021 | -29,191.00 |
| Jun 30, 2021 | 17,859.00 |
| Mar 31, 2021 | 13,980.00 |
| Dec 31, 2020 | -20,605.00 |
| Sep 30, 2020 | 3,426.00 |
| Jun 30, 2020 | -6,948.00 |
| Mar 31, 2020 | -8,177.00 |
| Dec 31, 2019 | -12,300.00 |
| Sep 30, 2019 | 2,547.00 |
| Jun 30, 2019 | 7,128.00 |
| Mar 31, 2019 | 1,573.00 |
| Dec 31, 2018 | 37,495.00 |
| Sep 30, 2018 | -12,357.00 |